Compare AMAR REMEDIES with BATA INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BATA INDIA - Comparison Results

BATA INDIA 
   Change

Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BATA INDIA AMAR REMEDIES/
BATA INDIA
 
P/E (TTM) x -0.5 40.6 - View Chart
P/BV x 0.1 8.8 0.7% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 AMAR REMEDIES   BATA INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BATA INDIA
Mar-19
AMAR REMEDIES/
BATA INDIA
5-Yr Chart
Click to enlarge
High Rs1641,426 11.5%   
Low Rs86732 11.7%   
Sales per share (Unadj.) Rs261.6228.0 114.7%  
Earnings per share (Unadj.) Rs17.425.6 67.9%  
Cash flow per share (Unadj.) Rs22.330.6 72.9%  
Dividends per share (Unadj.) Rs06.25 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.7135.5 74.3%  
Shares outstanding (eoy) m26.16128.53 20.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.54.7 10.1%   
Avg P/E ratio x7.242.1 17.1%  
P/CF ratio (eoy) x5.635.3 15.9%  
Price / Book Value ratio x1.28.0 15.6%  
Dividend payout %024.4 0.0%   
Avg Mkt Cap Rs m3,270138,671 2.4%   
No. of employees `000NA4.9 0.0%   
Total wages/salary Rs m1633,311 4.9%   
Avg. sales/employee Rs ThNM5,994.1-  
Avg. wages/employee Rs ThNM677.1-  
Avg. net profit/employee Rs ThNM672.8-  
INCOME DATA
Net Sales Rs m6,84429,311 23.3%  
Other income Rs m21682 3.1%   
Total revenues Rs m6,86529,993 22.9%   
Gross profit Rs m1,1314,771 23.7%  
Depreciation Rs m128641 20.0%   
Interest Rs m39836 1,121.1%   
Profit before tax Rs m6264,777 13.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1211,487 8.1%   
Profit after tax Rs m4553,290 13.8%  
Gross profit margin %16.516.3 101.5%  
Effective tax rate %19.331.1 62.1%   
Net profit margin %6.611.2 59.2%  
BALANCE SHEET DATA
Current assets Rs m4,90418,405 26.6%   
Current liabilities Rs m3,5816,297 56.9%   
Net working cap to sales %19.341.3 46.8%  
Current ratio x1.42.9 46.9%  
Inventory Days Days124105 118.9%  
Debtors Days Days1008 1,212.2%  
Net fixed assets Rs m1,6893,300 51.2%   
Share capital Rs m262643 40.8%   
"Free" reserves Rs m2,35816,776 14.1%   
Net worth Rs m2,63517,418 15.1%   
Long term debt Rs m5070-   
Total assets Rs m6,86224,741 27.7%  
Interest coverage x2.6135.6 1.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.2 84.2%   
Return on assets %12.413.4 92.5%  
Return on equity %17.318.9 91.4%  
Return on capital %31.027.6 112.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273130 210.3%   
Fx outflow Rs m23,420 0.1%   
Net fx Rs m271-3,290 -8.2%   
CASH FLOW
From Operations Rs m-3133,451 -9.1%  
From Investments Rs m-489-2,777 17.6%  
From Financial Activity Rs m769-631 -121.7%  
Net Cashflow Rs m-3343 -75.8%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 53.0 -  
Indian inst/Mut Fund % 9.2 9.8 93.9%  
FIIs % 0.0 20.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 17.1 381.9%  
Shareholders   13,061 83,621 15.6%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GILLETTE INDIA  RELAXO FOOTWEARS  COLGATE  ARCHIES LTD  K.S.OILS LTD  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

BATA INDIA Announces Quarterly Results (3QFY20); Net Profit Up 13.6% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, BATA INDIA has posted a net profit of Rs 1 bn (up 13.6% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA Announces Quarterly Results (2QFY20); Net Profit Up 28.2% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, BATA INDIA has posted a net profit of Rs 714 m (up 28.2% YoY). Sales on the other hand came in at Rs 7 bn (up 7.3% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA Announces Quarterly Results (1QFY20); Net Profit Up 22.0% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, BATA INDIA has posted a net profit of Rs 1 bn (up 22.0% YoY). Sales on the other hand came in at Rs 9 bn (up 10.6% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of BATA INDIA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BATA INDIA. Also includes updates on the valuation of BATA INDIA.

BATA INDIA Announces Quarterly Results (4QFY19); Net Profit Up 69.5% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, BATA INDIA has posted a net profit of Rs 883 m (up 69.5% YoY). Sales on the other hand came in at Rs 7 bn (up 7.4% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS